The role of TRPV1 ion channels in the suppression of gastric cancer development

• Published in: Journal of experimental & clinical cancer research 2020-10, Vol.39 (1), p.1-206, Article 206
• Main Authors: Gao, Nannan, Yang, Feng, Chen, Siyuan, Wan, Hanxing, Zhao, Xiaoyan, Dong, Hui
• Format: Article
• Language: English
• Subjects: Analysis; Antibodies; Apoptosis; Calcium signaling; Cancer; Cancer metastasis; Cell growth; Cholecystokinin; Cloning; Colorectal cancer; Gastric cancer; Invasion; Kinases; Metastasis; Pathogenesis; Plasmids; Proliferation; Proteins; Reagents; RNA; Stomach cancer; TRPV1 channel; Tumorigenesis; Vascular endothelial growth factor
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/s13046-020-01707-7

Background Although the aberrant expression and function of most Ca.sup.2+-permeable channels are known to promote gastrointestinal tumors, the association between transient receptor potential vanilloid receptor 1 (TRPV1) channels and gastric cancer (GC) has not yet been explored. Herein, we sought to determine the role of TRPV1 channels in the development of GC and to elucidate the underlying molecular mechanisms involved therein. Methods Immunohistochemistry, qPCR, Western blot, immunofluorescence assays were used to detect the mRNA and protein expression of TRPV1 in GC cells and tissues, and the clinical significance of TRPV1 in GC was also studied by clinicopathologic analysis. CCK8, colony formation, flow cytometry assays were used to detect the proliferation and survival of GC cells, while transwell assay was used to detect migration and invasion of GC cells in vitro. Tumor xenograft and peritoneal dissemination assays in nude mice were used to examine the role of TRPV1 in GC development in vivo. Results TRPV1 expression was significantly downregulated in human primary GC tissues compared to their adjacent tissues. The decreased expression of TRPV1 proteins in GC tissues was positively correlated with tumor size, histological grade, lymphatic metastasis, clinical stage, and was strongly correlated with poor prognosis of GC patients. Moreover, the expression of TRPV1 was closely correlated with Ki67, VEGFR, and E-cadherin, all of which are the well-known cancer markers for proliferation and metastasis. TRPV1 proteins were predominately expressed on the plasma membrane in several GC cell lines. TRPV1 overexpression blocked cell cycle at G1 phase to inhibit GC cell proliferation and attenuated migration and invasion of GC cells in vitro, but TRPV1 knockdown increased these parameters. TRPV1 significantly reduced gastric tumor size, number and peritoneal dissemination in vivo. Mechanistically, TRPV1 overexpression in GC cells increased [Ca.sup.2+].sub.i, activated CaMKK[beta] and AMPK phosphorylation, and decreased expression of cyclin D1 and MMP2, while TRPV1 knockdown induced the opposite effects. Conclusions TRPV1 uniquely suppresses GC development through a novel Ca.sup.2+/CaMKK[beta]/AMPK pathway and its downregulation is correlated with poor survival of human GC patients. Thus, TRPV1 upregulation and its downstream signaling may represent a promising target for GC prevention and therapy. Keywords: TRPV1 channel, Calcium signaling, Gastric cancer, P